Cambridge Financial Group’s Gilead Sciences GILD Stock Holding History

Cambridge Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-53,051	Closed	-$5.37M	–	35
2015 Q4	$5.37M	Sell	53,051 -1,174	-2%	-$122K	3.21%	22
2015 Q3	$5.32M	Sell	54,225 -2,500	-4%	-$278K	3.18%	19
2015 Q2	$6.64M	Sell	56,725 -1,145	-2%	-$125K	3.54%	8
2015 Q1	$5.68M	Buy	57,870 +51,925	+873%	+$5.27M	2.81%	29
2014 Q4	$560K	Sell	5,945 -73,123	-92%	-$7.56M	2.72%	29
2014 Q3	$8.42M	Sell	79,068 -9,890	-11%	-$968K	4.21%	1
2014 Q2	$7.38M	Sell	88,958 -1,144	-1%	-$89K	3.67%	5
2014 Q1	$6.38M	Sell	90,102 -11,195	-11%	-$878K	3.25%	18
2013 Q4	$7.61M	Sell	101,297 -7,562	-7%	-$527K	3.88%	2
2013 Q3	$6.84M	Sell	108,859 -9,140	-8%	-$546K	3.77%	4
2013 Q2	$7.25M	Buy	+117,999	New	+$6.15M	3.65%	4

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cambridge Financial Group's GILD Position: Q1 2016 in Review

Cambridge Financial Group sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 53,051 shares — an estimated $5.37M sold.

Cambridge Financial Group first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $8.42M in Q3 2014. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Cambridge Financial Group reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
Cambridge Financial Group sold 53,051 Gilead Sciences shares in Q1 2016, an estimated $5.37M.
Cambridge Financial Group first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Cambridge Financial Group's Gilead Sciences position peaked at $8.42M in Q3 2014.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Cambridge Financial Group's 13F filing for Q1 2016, filed 16 May 2016.